A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants

NCT02629289 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia

Interventions

DRUG: HSP-130
DRUG: US-approved Neulasta
DRUG: EU-approved Neulasta

Sponsor

Pfizer

Collaborators

[object Object]